مباشر

FierceBiotech‘We think about it every day’: How Daiichi Sankyo’s R&D chief plans to stay ahead in the ADC game Clinical OMICsHave Microbubbles Burst Through the Barriers of Genetic Medicine Delivery?Clinical OMICsOLE Identified as a Potential Alzheimer’s Therapy Targeting Microglia Endpoints NewsFDA gives rejected drugs another chance in post-Makary era Clinical OMICsAI Discovers Two New Antibiotics for Drug-Resistant Gonorrhea Clinical OMICsGLP-1 Drugs Reduce Crime-Linked Behavior Clinical OMICsMacrophage EGFR Activity Linked to Immune Suppression, Tumor Growth in Colorectal Cancer Clinical OMICsUnexpected Role for RNA Editing in Cancer Immune Evasion Uncovered Clinical OMICsProactive Surveillance Pays Off for Patients with Li-Fraumeni Syndrome Clinical OMICsCAR T Success Hinges on Microenvironment Response in GBM Endpoints NewsFDA warns telehealth companies over compounded GLP-1s BioPharma DiveUniQure to file gene therapy for approval, reflecting major shifts at FDA

Clinical OMICs ١٧ يونيو ٢٠٢٦

Have Microbubbles Burst Through the Barriers of Genetic Medicine Delivery?

Kenneth Greenberg, PhD, SonoThera co-founder and CEO, dives into the translatability of SonoThera's ultrasound-mediated nonviral platform that’s shown paradigm-...

Kenneth Greenberg, PhD, SonoThera co-founder and CEO, dives into the translatability of SonoThera's ultrasound-mediated nonviral platform that’s shown paradigm-shifting potential. The post Have Microbubbles Burst Through the Barriers of Genetic Medicine Delivery? appeared first on Inside Precision Medicine .